Insmed Incorporated (Nasdaq:INSM) on 15 December 2014 provides a regulatory and clinical update on the Company’s development programs. The company has submitted its Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) and is awaiting its validation. The Company has been informed by the EMA that the remaining item to be addressed prior to validation is the approval of the Pediatric Investigation Plan (PIP) by the EMA’s Pediatric Committee, which is expected to be completed in the first quarter of 2015. Insmed Incorporated (NASDAQ:INSM) in last trading activity moved up 1.04% to close at $15.53. Company weekly performance is -5.42% while its quarterly performance stands at 14.95%. Insmed Incorporated (NASDAQ:INSM) is -30.33% away from its 52 week high.
Analysts at Zacks reiterated a “neutral” rating on shares of American International Group, Inc. (NYSE:AIG) in a research note on Tuesday, December 23rd. On last trading day American International Group, Inc. (NYSE:AIG) moved up 0.12% to close at $56.49. Its volatility for the week is 0.91% while volatility for the month is 1.47%. AIG’s EPS growth for past 5 years was 15.00%. American International Group, Inc. (NYSE:AIG) monthly performance is 3.69%.
Fresenius Medical Care AG & Co. (NYSE:FMS) was downgraded by research analysts at Bryan Garnier & Cie to a “neutral” rating in a report released on Thursday, 18 December 2014. On last trading day Fresenius Medical Care AG & Co. KGAA (NYSE:FMS) moved up 0.24% to close at $37.34. Its volatility for the week is 0.83% while volatility for the month is 1.02%. FMS’s sales growth for past 5 years was 6.60% and its EPS growth for past 5 years was 21.50%. Fresenius Medical Care AG & Co. KGAA (NYSE:FMS) monthly performance is 0.43%.
Greenhunter Resources (NYSE:GRH) last announced its earnings results on Tuesday, November 4th. The company reported ($0.08) EPS for the quarter, meeting the Thomson Reuters consensus estimate of ($0.08). The company had revenue of $6.26 million for the quarter, compared to the consensus estimate of $8.70 million. The company’s quarterly revenue was down 19.2% on a year-over-year basis. On average, analysts predict that Greenhunter Resources will post $-0.30 earnings per share for the current fiscal year. GreenHunter Resources, Inc. (NYSEMKT:GRH) has 11.30% insider ownership while its institutional ownership stands at 9.20%. In last trading activity company’s stock closed at $0.73.
Point.360 (NASDAQ:PTSX) begins trading on 03 December 2014 on OTCQX under the symbol “PTSX.” “We are pleased to welcome Point.360 to the OTCQX marketplace,” said R. Cromwell Coulson, President and CEO of OTC Markets Group. “Trading on OTCQX will allow Point.360 to maintain a high-quality trading and information experience for its investors without the cost and complexity of a stock exchange listing. We look forward to working with the company as it continues to grow its business on OTCQX.” On Monday shares of Point.360 (NASDAQ:PTSX) closed at $0.48.